Stay updated on SBRT+Nivolumab/Ipilimumab in RCC Clinical Trial
Sign up to get notified when there's something new on the SBRT+Nivolumab/Ipilimumab in RCC Clinical Trial page.

Latest updates to the SBRT+Nivolumab/Ipilimumab in RCC Clinical Trial page
- ChecktodayChange DetectedRevision: v3.5.0 was added and v3.4.3 was removed, indicating a site version update.SummaryDifference0.1%

- Check7 days agoChange DetectedPage revision updated: v3.4.3 added and v3.4.2 removed.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedThe page now shows Revision: v3.4.2 instead of v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check43 days agoChange DetectedThe new screenshot shows an updated revision label: v3.4.1 replaces v3.4.0. No substantive changes to study details, eligibility criteria, outcomes, or navigation were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check50 days agoChange DetectedAdded a glossary toggle and updated metadata labels (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0) while removing older labels (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4). These changes do not affect the study content, eligibility, endpoints, or results, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check65 days agoChange DetectedAn added Revision: v3.3.4 and removal of Revision: v3.3.3 are shown. These are internal version updates and do not modify the study details or user-facing content.SummaryDifference0.1%

Stay in the know with updates to SBRT+Nivolumab/Ipilimumab in RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SBRT+Nivolumab/Ipilimumab in RCC Clinical Trial page.